COVID Unrest, Health Sector Deep Freeze Hits Chinese Biotechs Hard

Some Already Responding To Challenges

 
• By Brian Yang
  
Beijing relies on mass PCR testing to contain virus spreading in Nov. 2022
China's COVID Zero policies, which rely on mass testing like this in Beijing, are hitting biotechs hard • Source: Shutterstock

More from COVID-19

More from Scrip